Mendelian randomization analysis of two samples to determine the impact of immune cells on bronchitis
Zhiyu Tian,Zhanliang Jiang,Li Shi
DOI: https://doi.org/10.1097/md.0000000000040541
IF: 1.6
2024-12-01
Medicine
Abstract:Bronchitis is a common respiratory disease characterized by inflammation of the inner layer of the bronchial wall, posing a significant public health challenge due to its impact on respiratory function. The disease is classified into 2 main types: acute and chronic, each with its unique pathophysiological characteristics. [ 1 ] Acute bronchitis is primarily triggered by viral infections, manifesting as temporary inflammation of the airways, leading to coughing and mucus production. [ 2 ] Chronic bronchitis is a more persistent condition, defined as the presence of cough and mucus production for at least 3 months in 2 consecutive years, typically attributed to long-term exposure to irritants, such as tobacco smoke and environmental pollution. [ 3 ] The progression of bronchitis involves a complex interplay of environmental, genetic, and infectious factors. Acute episodes are mainly viral, but bacterial infections can exacerbate or prolong the disease. [ 4 ] Chronic bronchitis is closely associated with exposure to smoking and air pollutants, although genetic predispositions also play a role. [ 5 ] Treatment approaches vary according to the type and severity of bronchitis, ranging from supportive care and symptom management in acute cases to comprehensive strategies for chronic cases, including smoking cessation, pharmacotherapy, and pulmonary rehabilitation. [ 6 ] These strategies aim not only to alleviate symptoms but also to improve quality of life and reduce the risk of complications. Current research in the field of bronchitis focuses on unveiling the disease's molecular and immune mechanisms, identifying new therapeutic targets, and evaluating the effectiveness of emerging treatment methods. [ 7 ] Studies show that immune cells act through various mechanisms to combat pathogens and maintain lung health. The initial response of the immune system involves innate immune cells, such as macrophages and dendritic cells, which recognize specific molecular patterns of pathogens through pattern recognition receptors, thereby triggering the release of a series of inflammatory mediators. [ 8 ] These mediators, including cytokines and chemokines, not only promote the migration of neutrophils and monocytes to the infected area, enhancing phagocytosis, but also facilitate the intervention of the adaptive immune response. [ 9 ] In the adaptive immune response, the production of antibodies by B cells and the cytotoxic action of CD8+ T cells work together to clear pathogens. Additionally, CD4+ T cells coordinate the entire immune response by secreting cytokines. [ 10 ] After the infection is controlled, inflammation is reduced through regulatory T cells and other mechanisms, restoring tissue homeostasis, highlighting the complexity and precision of the immune system in maintaining respiratory health.
medicine, general & internal